Does LISOCABTAGENE MARALEUCEL Cause Lymphocyte adoptive therapy? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Lymphocyte adoptive therapy have been filed in association with LISOCABTAGENE MARALEUCEL (BREYANZI). This represents 3.4% of all adverse event reports for LISOCABTAGENE MARALEUCEL.
25
Reports of Lymphocyte adoptive therapy with LISOCABTAGENE MARALEUCEL
3.4%
of all LISOCABTAGENE MARALEUCEL reports
4
Deaths
19
Hospitalizations
How Dangerous Is Lymphocyte adoptive therapy From LISOCABTAGENE MARALEUCEL?
Of the 25 reports, 4 (16.0%) resulted in death, 19 (76.0%) required hospitalization, and 1 (4.0%) were considered life-threatening.
Is Lymphocyte adoptive therapy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LISOCABTAGENE MARALEUCEL. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does LISOCABTAGENE MARALEUCEL Cause?
Cytokine release syndrome (315)
Immune effector cell-associated neurotoxicity syndrome (129)
Neurotoxicity (101)
Pyrexia (47)
Fatigue (38)
Hypotension (38)
Febrile neutropenia (28)
Confusional state (27)
Death (25)
Malignant neoplasm progression (23)
What Other Drugs Cause Lymphocyte adoptive therapy?
AXICABTAGENE CILOLEUCEL (108)
CILTACABTAGENE AUTOLEUCEL (43)
BREXUCABTAGENE AUTOLEUCEL (22)
IBRUTINIB (18)
TISAGENLECLEUCEL (17)
IDECABTAGENE VICLEUCEL (13)
VENETOCLAX (9)
CYCLOPHOSPHAMIDE (8)
RITUXIMAB (8)
CISPLATIN (6)
Which LISOCABTAGENE MARALEUCEL Alternatives Have Lower Lymphocyte adoptive therapy Risk?
LISOCABTAGENE MARALEUCEL vs LITHIUM
LISOCABTAGENE MARALEUCEL vs LIXISENATIDE
LISOCABTAGENE MARALEUCEL vs LOBAPLATIN
LISOCABTAGENE MARALEUCEL vs LOFEXIDINE
LISOCABTAGENE MARALEUCEL vs LOMITAPIDE